MCKESSON CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 586.9 USD | +0.13% |
|
+3.04% | +26.77% |
| 12:18am | Top law firms in US opioid lawsuits to get hundreds of millions in fees | RE |
| Jun. 06 | Mckesson Insider Sold Shares Worth $2,155,761, According to a Recent SEC Filing | MT |
ETFs positioned on McKesson Corporation
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 6 M€ | -4.26% | - | |
| 0.00% | 11 M€ | +1.95% | - | |
| 0.01% | 32 M€ | +4.30% | - | |
| 4.84% | 132 M€ | +9.08% | - |
McKesson Corporation specializes in pharmaceutical product distribution. The group also offers technological services to healthcare companies. Net sales break down by activity as follows:
- distribution of pharmaceutical products (87%);
- distribution of medical and surgical products (4%);
- other (1.6%): primarily technology services and software sales.
The remaining net sales (7.4%) are from international activities.
Sector
Pharmaceuticals
Calendar
2024-07-30
- Q1 2025 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
586.9
USD
Average target price
589.5
USD
Spread / Average Target
+0.45%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +26.77% | 76.29B | |
| -2.27% | 23.99B | |
| +10.27% | 9.01B | |
| +12.25% | 8.67B | |
| -24.34% | 7.58B | |
| +12.70% | 5.18B | |
| +2.89% | 4.16B | |
| -4.96% | 3.98B | |
| -1.36% | 3.63B | |
| +20.13% | 3.58B |
- Stock Market
- Equities
- MCK Stock
- Funds and ETFs McKesson Corporation
